These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The promises and challenges of human brain organoids as models of neuropsychiatric disease. Quadrato G; Brown J; Arlotta P Nat Med; 2016 Nov; 22(11):1220-1228. PubMed ID: 27783065 [TBL] [Abstract][Full Text] [Related]
4. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. Liu YN; Lu SY; Yao J Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474 [TBL] [Abstract][Full Text] [Related]
5. Modeling neuropsychiatric disorders using human induced pluripotent stem cells. Wang M; Zhang L; Gage FH Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525 [TBL] [Abstract][Full Text] [Related]
6. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134 [TBL] [Abstract][Full Text] [Related]
7. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. van Hugte E; Nadif Kasri N Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501 [TBL] [Abstract][Full Text] [Related]
8. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder. Watmuff B; Liu B; Karmacharya R Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060 [TBL] [Abstract][Full Text] [Related]
9. Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders. Gurwitz D Dialogues Clin Neurosci; 2016 Sep; 18(3):267-276. PubMed ID: 27757061 [TBL] [Abstract][Full Text] [Related]
11. Mental health dished up-the use of iPSC models in neuropsychiatric research. McNeill RV; Ziegler GC; Radtke F; Nieberler M; Lesch KP; Kittel-Schneider S J Neural Transm (Vienna); 2020 Nov; 127(11):1547-1568. PubMed ID: 32377792 [TBL] [Abstract][Full Text] [Related]
12. Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. Scarnati MS; Halikere A; Pang ZP Alcohol; 2019 Feb; 74():83-93. PubMed ID: 30087005 [TBL] [Abstract][Full Text] [Related]
13. Modeling psychiatric disorders with patient-derived iPSCs. Wen Z; Christian KM; Song H; Ming GL Curr Opin Neurobiol; 2016 Feb; 36():118-27. PubMed ID: 26705693 [TBL] [Abstract][Full Text] [Related]
15. Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development. Heider J; Vogel S; Volkmer H; Breitmeyer R Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638595 [TBL] [Abstract][Full Text] [Related]
16. In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells. Korecka JA; Levy S; Isacson O Mol Cell Neurosci; 2016 Jun; 73():3-12. PubMed ID: 26691153 [TBL] [Abstract][Full Text] [Related]
17. Annual Research Review: The promise of stem cell research for neuropsychiatric disorders. Vaccarino FM; Urban AE; Stevens HE; Szekely A; Abyzov A; Grigorenko EL; Gerstein M; Weissman S J Child Psychol Psychiatry; 2011 Apr; 52(4):504-16. PubMed ID: 21204834 [TBL] [Abstract][Full Text] [Related]
18. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
20. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders. Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]